Table 3.
Baseline clinical characteristics of patients in the maintained sinus rhythm (MSR) group as compared to the atrial fibrillation recurrence (AFR) group
| MSR (27) n (%) | AFR (14) n (%) | P value | |
|---|---|---|---|
| Mean age (years) |
65 ± 5.0 |
64 ± 6.8 |
0.9 |
| Sex (M/F) |
21/6 |
8/6 |
0.28 |
| BMI (Kg/m2) |
32 ± 3.0 |
34 ± 3.6 |
0.26 |
|
Comorbid conditions: |
|
|
|
| HTN |
21 (77.8) |
12 (85.7) |
0.69 |
| CAD |
9 (33.3) |
5 (35.7) |
1.0 |
| Systolic HF |
11 (40.7) |
3 (21.4) |
0.3 |
| CVA |
0 (0) |
1 (7.1) |
0.34 |
| DM |
5 (18.5) |
6 (42.8) |
0.14 |
| Dyslipidemia |
16 (59.2) |
8 (57.1) |
1.0 |
|
Medications: |
|
|
|
| Statins |
14 (51.8) |
8 (57.1) |
1.0 |
| Beta blockers |
20 (74.1) |
7 (50.0) |
0.17 |
| ACE-i/ARB |
14 (51.8) |
11 (78.5) |
0.17 |
| CCB |
12 (44.5) |
6 (42.8) |
1.0 |
| Digoxin |
2 (7.4) |
2 (14.3) |
0.59 |
| Diuretics |
16 (59.2) |
5 (35.7) |
0.19 |
| ASA |
18 (66.7) |
12 (85.7) |
0.28 |
| Clopidogrel |
1 (3.7) |
1 (7.1) |
1.0 |
| Warfarin |
18 (66.7) |
10 (71.4) |
1.0 |
| Heparin |
1 (3.7) |
3 (21.4) |
0.11 |
| Amiodarone |
7 (25.9) |
1 (7.1) |
0.23 |
| Sotalol |
2 (7.4) |
3 (21.4) |
0.32 |
| Other anti-arrhythmics | 3 (11.1) | 1 (7.1) | 1.0 |
BMI – Body Mass Index, HTN – Hypertension, CAD – Coronary artery disease, HF- Heart failure, DM – Diabetes Mellitus, CVA – Cerebrovascular accident, ACE-i/ARB – Angiotensinogen converting enzyme inhibitors/Angiotensin receptor blockers, CCB – Calcium channel blockers, ASA - Aspirin.